Events

2024-07-22

The First Clinical Gene Editing Therapy to Treat An Overseas Patient in China

More

2024-07-19

CS-101 Clinical Result Included in EHA2024 Scientific Congress Report

More

2024-06-06

CorrectSequence Therapeutics to Participate in EHA2024 Hybrid Congress

More

2024-06-03

CorrectSequence Therapeutics to Participate in BIO International Convention 2024

More

2024-04-13

CorrectSequence Therapeutics to Participate in the 27th Annual Meeting of American Society of Gene & Cell Therapy

More

2024-04-02

CorrectSequence Therapeutics’ Base Editing Drug "CS-101 Injection" Obtains IND Approval from the NMPA

More

2024-01-16

Jia Chen, Co-founder of CorrectSequence Therapeutics to Participate in the 5th International Conference on Base Editing, Prime Editing & Related Enzymes

More

2024-01-08

The World’s First Clinical Base Editing Therapy for Hemoglobinopathy

More

2023-11-24

Cell Stem Cell | A novel strategy for treating β-hemoglobinopathy based on the transformer base editor (tBE)

More

2023-10-17

CorrectSequence Therapeutics to Participate in the 18th ASCAT Conference

More

Press Release

2023-01-11

PHARMCUBE Colum | Dr. Xiaodun Mou: Base Editing Therapy is Expected to Open a New Chapter of Disease Treatment

More

2022-10-12

[Sequoia Talk] Jiang Han x Xiaodun Mou: Turning Scissor into Pen, Base Editing Technology Leads Cell and Gene Therapy into Minimally Invasive Era

More

2022-08-01

Develop Innovative Base Editing System and Nearly 10 Pipelines, 1st Pipeline be IND Ready By 2023

More

2022-07-14

Chinese First Base Editing Tool Authorized by Overseas Patent

More

2021-03-27

Turning a Scissor into a Pen, CRISPR 2.0 Era is Coming

More

Our Culture

  • Mission

    We use innovative 

    base editing technology 

    to help people 

    with severe diseases

  • Vision

    To be the Chinese leading 

    and world-class 

    gene editing innovative 

    pharmaceutical company

  • Value

    Patient first，REsponsibility，Collaboration，Innovation，

    Strive for Excellence

    P R E C I S E

CorrectSequence Therapeutics Co., Ltd. © (2021-2022)
沪ICP备2020032248号
Powered by MetInfo 7.7 ©2008-2024  mituo.cn
HOME
ABOUT
NEWS
CONTACT